36 hours ago If you are a patient that had COVID-19 testing performed by Aegis, use the button below to view … >> Go To The Portal
For inquiries concerning Aegis’s collaboration with HHS, and/or testing for federal, state, and local governmental entities, please contact Joel Galanter, Chief Legal Officer, joel.galanter@aegislabs.com
On April 14 th , Centers for Medicare and Medicaid Services (CMS) announced new procedure codes and associated pricing for COVID-19 testing performed utilizing high-throughput technologies capable of processing large volumes of COVID-19 tests rapidly.
Aegis TAT is measured from the time samples are logged into our laboratory tracking system until test reports are released. It does not include transit time to lab. Aegis works with all of its collection partners to maximize the use of overnight shipping to its lab after collection. Shipping delays and weekend shipping schedules may impact the length of time between the collection event and the final Aegis report.
For inquiries concerning Aegis’s collaboration with HHS, and/or testing for federal, state, and local governmental entities, please contact Joel Galanter, Chief Legal Officer, joel.galanter@aegislabs.com
On April 14 th , Centers for Medicare and Medicaid Services (CMS) announced new procedure codes and associated pricing for COVID-19 testing performed utilizing high-throughput technologies capable of processing large volumes of COVID-19 tests rapidly.
Aegis TAT is measured from the time samples are logged into our laboratory tracking system until test reports are released. It does not include transit time to lab. Aegis works with all of its collection partners to maximize the use of overnight shipping to its lab after collection. Shipping delays and weekend shipping schedules may impact the length of time between the collection event and the final Aegis report.
Aegis utilizes a transport media (PrimeStore MTM) to improve stability of COVID-19 diagnostic specimens while in transit. Our internal studies have demonstrated stability of viral specimens up to 14 days at room temperature in PrimeStore MTM. For more information on PrimeStore® MTM stability please visit: PrimeStore® MTM
For inquiries concerning Aegis’s collaboration with HHS, and/or testing for federal, state, and local governmental entities, please contact Joel Galanter, Chief Legal Officer, joel.galanter@aegislabs.com
Additionally, the New England Journal of Medicine has provided an instructional video on collection of nasopharyngeal specimens.
Aegis currently utilizes a molecular real-time RT-PCR assay manufactured by Thermo Fisher Scientific, Inc. known as the TaqPath COVID-19 Combo Kit, which is used in accordance with the manufacturer's EUA authorization. Aegis' in-house verification of the performance of the aforementioned assay demonstrated.
Aegis TAT is measured from the time samples are logged into our laboratory tracking system until test reports are released. It does not include transit time to lab. Aegis works with all of its collection partners to maximize the use of overnight shipping to its lab after collection. Shipping delays and weekend shipping schedules may impact the length of time between the collection event and the final Aegis report.
Supervisory guidelines may be altered, including for resident trainees. Telehealth opportunities are also increased. Physicians and extenders should consult their local state boards to ensure that any COVID-19-related practice initiatives align with state law and the provider's scope of practice.
A comprehensive set of instructions have been developed for specimen collection and shipment. Contact Aegis with any questions on this process at 1-800-533-7052.